XML 55 R40.htm IDEA: XBRL DOCUMENT v3.23.2
LONG-TERM DEBT (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 21, 2023
Mar. 21, 2023
Dec. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Line of Credit Facility [Line Items]                
Amortization of debt discount premium         $ 115,000   $ 153,842
Avenue [Member]                
Line of Credit Facility [Line Items]                
Warrant to purchase stock   $ 1,200,000            
Exercise price   $ 1.24 $ 1.24          
Warrants term   5 years 5 years          
Fair value of warrants $ 1,100,000              
Debt conversion amount   $ 2,000,000            
Conversion price per share   $ 1.49 $ 1.49          
Avenue Facility [Member]                
Line of Credit Facility [Line Items]                
Line of credit amount   $ 40,000,000 $ 40,000,000          
Line of credit   15,000,000            
Line of credit   $ 20,000,000            
Debt instrument description   The Company incurred other fees associated with the Avenue Facility including: (1) a $300 thousand financing fee, (2) a $200 thousand upfront commitment fee of 1% of the total $20 million in committed capital and (3) $27 thousand in legal fees. The total debt discount recorded of $1.6 million will be amortized over a forty-two-month period            
Line of Credit Facility, Expiration Date   Oct. 01, 2026            
Debt Instrument, Interest Rate Terms             interest is based on the greater of: (1) the Prime Rate (as defined in the Supplement) plus 4.75% and (2) 12.5%. At June 30, 2023, the interest rate was 12.75%. Payments are interest only until November 2024  
Proceeds from Issuance of Debt   $ 15,000,000.0            
Proceeds from Debt, Net of Issuance Costs   12,300,000            
Repayments of Long-Term Debt   $ 2,000,000            
Line of credit, description   The Company is subject to certain affirmative and negative covenants under the Avenue Facility, including the requirement, beginning on the closing date, to maintain at least $5 million of unrestricted cash to be tested at the end of each month, and beginning on the period ended September 30, 2023, and at the end of each quarter thereafter, a trailing six-month cash flow The Company is subject to certain affirmative and negative covenants under the Avenue Facility, including the requirement, beginning on the closing date, to maintain at least $5 million of unrestricted cash to be tested at the end of each month, and beginning on the period ended September 30, 2023, and at the end of each quarter thereafter, a trailing six-month cash flow          
Debt instrument, face amount   $ 15,000,000 $ 15,000,000          
Interest expense, debt         $ 598 $ 0 $ 694 $ 0
Avenue Facility [Member] | Series B Preferred Stock [Member]                
Line of Credit Facility [Line Items]                
Preferred Stock, Liquidation Preference, Value   $ 5,000,000 $ 5,000,000          
Avenue Facility [Member] | Forecast [Member]                
Line of Credit Facility [Line Items]                
Line of credit       $ 5,000,000